Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Matinas Biopharma Holdings, Inc. (MTNB) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Matinas Biopharma Holdings, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1582554.
Total stock buying since 2017: $1,138,873.
Total stock sales since 2017: $0.
Total stock option exercises since 2017: $139,203.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 140,000 | $102,700 | 0 | $0 | 278,407 | $139,203 |
| 2019 | 797,037 | $741,673 | 0 | $0 | 0 | $0 |
| 2017 | 220,000 | $294,500 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-08 | 20,000 | $16,600 | 0 | $0 | 0 | $0 |
| 2020-05 | 100,000 | $73,100 | 0 | $0 | 0 | $0 |
| 2020-04 | 0 | $0 | 0 | $0 | 278,407 | $139,203 |
| 2020-03 | 20,000 | $13,000 | 0 | $0 | 0 | $0 |
| 2019-11 | 194,500 | $220,466 | 0 | $0 | 0 | $0 |
| 2019-08 | 165,050 | $116,005 | 0 | $0 | 0 | $0 |
| 2019-06 | 82,487 | $68,077 | 0 | $0 | 0 | $0 |
| 2019-05 | 355,000 | $337,125 | 0 | $0 | 0 | $0 |
| 2017-09 | 220,000 | $294,500 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-08-21 | Stern Adam K | Buy | 20,000 | .83 | 16,600 |
| 2020-05-14 | Lepore Patrick G | Buy | 100,000 | .73 | 73,100 |
| 2020-04-03 | Stern Adam K | Option Ex | 278,407 | .50 | 139,203 |
| 2020-03-17 | Jabbour Jerome D (President and CEO) | Buy | 10,000 | .65 | 6,500 |
| 2020-03-17 | Stern Adam K | Buy | 10,000 | .65 | 6,500 |
| 2019-11-25 | Kucinski Keith A (Chief Financial Officer) | Buy | 58,000 | 1.23 | 71,166 |
| 2019-11-22 | Kucinski Keith A (Chief Financial Officer) | Buy | 36,500 | 1.20 | 43,800 |
| 2019-11-15 | Lepore Patrick G | Buy | 100,000 | 1.05 | 105,500 |
| 2019-08-20 | Ende Eric J | Buy | 20,000 | .66 | 13,200 |
| 2019-08-19 | Jabbour Jerome D (President and CEO) | Buy | 14,650 | .68 | 9,976 |
| 2019-08-19 | Ende Eric J | Buy | 20,000 | .68 | 13,660 |
| 2019-08-19 | Stern Adam K | Buy | 10,400 | .70 | 7,269 |
| 2019-08-16 | Lepore Patrick G | Buy | 100,000 | .72 | 71,900 |
| 2019-06-14 | Stern Adam K | Buy | 15,000 | .80 | 12,000 |
| 2019-06-12 | Jabbour Jerome D (President and CEO) | Buy | 12,487 | .80 | 9,977 |
| 2019-06-12 | Stern Adam K | Buy | 20,000 | .80 | 16,000 |
| 2019-06-10 | Stern Adam K | Buy | 15,000 | .82 | 12,300 |
| 2019-06-07 | Stern Adam K | Buy | 20,000 | .89 | 17,800 |
| 2019-05-31 | Stern Adam K | Buy | 80,000 | .94 | 75,200 |
| 2019-05-16 | Stern Adam K | Buy | 150,000 | .95 | 142,500 |
| 2019-05-16 | Conrad Herbert J | Buy | 25,000 | .96 | 24,125 |
| 2019-05-16 | Lepore Patrick G | Buy | 100,000 | .95 | 95,300 |
| 2017-09-11 | Mannino Raphael J (Chief Scientific Officer) | Buy | 5,000 | 1.41 | 7,050 |
| 2017-09-08 | Rongen Roelof (Chief Executive Officer) | Buy | 5,000 | 1.36 | 6,800 |
| 2017-09-08 | Stern Adam K | Buy | 50,000 | 1.38 | 69,000 |
| 2017-09-07 | Ferrari Stefano | Buy | 5,000 | 1.24 | 6,200 |
| 2017-09-07 | Stern Adam K | Buy | 50,000 | 1.38 | 69,000 |
| 2017-09-07 | Scibetta James S | Buy | 5,000 | 1.29 | 6,450 |
| 2017-09-07 | Conrad Herbert J | Buy | 100,000 | 1.30 | 130,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of MTNB listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Matinas Biopharma Holdings, Inc. (symbol MTNB, CIK number 1582554) see the Securities and Exchange Commission (SEC) website.